Page last updated: 2024-09-05

ly 353381 and osteoprotegerin

ly 353381 has been researched along with osteoprotegerin in 1 studies

Compound Research Comparison

Studies (ly 353381)	Trials (ly 353381)	Recent Studies (post-2010) (ly 353381)	Studies (osteoprotegerin)	Trials (osteoprotegerin)	Recent Studies (post-2010) (osteoprotegerin)
70	12	15	5,108	212	2,726

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Biskobing, DM; Downs, R; Novy, AM	1

Reviews

1 review(s) available for ly 353381 and osteoprotegerin

Article	Year
Novel therapeutic options for osteoporosis. Current opinion in rheumatology, 2002, Volume: 14, Issue:4 Topics: Animals; Controlled Clinical Trials as Topic; Diphosphonates; Disease Models, Animal; Evidence-Based Medicine; Fractures, Spontaneous; Glycoproteins; Humans; Ibandronic Acid; Imidazoles; Norpregnenes; Osteoporosis; Osteoprotegerin; Piperidines; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Selective Estrogen Receptor Modulators; Thiophenes; Zoledronic Acid	2002

Article

Year

Novel therapeutic options for osteoporosis.

Current opinion in rheumatology, 2002, Volume: 14, Issue:4

Topics: Animals; Controlled Clinical Trials as Topic; Diphosphonates; Disease Models, Animal; Evidence-Based Medicine; Fractures, Spontaneous; Glycoproteins; Humans; Ibandronic Acid; Imidazoles; Norpregnenes; Osteoporosis; Osteoprotegerin; Piperidines; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Selective Estrogen Receptor Modulators; Thiophenes; Zoledronic Acid

2002